NLRP3 and dry eye syndrome: Bruton’s tyrosine kinase (BTK) is mainly expressed on KCs and sinusoidal endothelial cells, and BTK inhibitor ibrutinib effectively attenuates liver I/R injury by suppressing activation of the NLRP3 inflammasome in KCs (52).